Results 51 to 60 of about 5,534 (181)
Society for Maternal‐Fetal Medicine Consult Series #76: Cancer in pregnancy
Abstract Approximately one in 1000 pregnancies is complicated by the diagnosis of cancer each year, and the incidence of cancer among reproductive‐age individuals is increasing. Management of a pregnant person with cancer can be complex and warrants a multidisciplinary approach to care.
Society for Maternal‐Fetal Medicine (SMFM) +6 more
wiley +1 more source
Sarcomas are very complex and clinically challenging mesenchymal tumors. Although the standard therapeutic approach has improved the 5-year survival rate, many patients experience local relapses and/or distant metastases.
Giulia Calafato +3 more
doaj +1 more source
Diffuse large B‐cell lymphoma (DLBCL) is characterized by profound heterogeneity that underpins varied clinical outcomes. To decipher this complexity, we performed an integrated single‐cell and genomic analysis. Using scRNA‐seq data (GSE182434), we identified six distinct malignant B‐cell subclusters (MB1‐MB6) within the DLBCL ecosystem.
Hongyu Shen +7 more
wiley +1 more source
Individually Specified Drug Immunoconjugates in Cancer Treatment
Forty-three patients with disseminated refractory malignancies each received an individually-specified combination of either Adriamycin (24 patients) or mitomycin-C (19 patients) conjugated murine monoclonal antibodies. Tumors were typed using a panel of
R.K. Oldham +6 more
doaj +1 more source
Accumulating evidence suggests that tissue factor (TF) is selectively expressed in pathological angiogenesis-dependent as well as macrophage-associated human diseases.
Zhiwei Hu
doaj +1 more source
An Overview of Emerging Trends in Targeted Therapy of Triple‐Negative Breast Cancer
Triple‐negative breast cancer (TNBC) is a biologically diverse, highly aggressive class of breast cancer defined by the absence of estrogen, progesterone, and HER2 receptors. It accounts for approximately 10%–20% of all invasive breast cancers, and disproportionately affects women of younger ages and from minority groups.
Anuj Kumar +2 more
wiley +1 more source
Novel Bioconjugate Materials: Synthesis, Characterization and Medical Applications
This review discusses the bioconjugation of novel materials grouped under “biological”, “hybrid” and “synthetic” categories. Medical applications ranging from cancer therapy and diagnostics to optogenetics and tissue engineering are explored, and conjugation trends are highlighted as a general guide. The review concludes with a comparison of techniques
Ellie Martin +6 more
wiley +1 more source
Citation: 'immunoconjugate' in the IUPAC Compendium of Chemical Terminology, 5th ed.; International Union of Pure and Applied Chemistry; 2025. Online version 5.0.0, 2025. 10.1351/goldbook.13279 • License: The IUPAC Gold Book is licensed under Creative Commons Attribution-ShareAlike CC BY-SA 4.0 International for individual terms.
REIS E SOUSA CAETANO, SCHULZ OLIVER
openaire +3 more sources
Schematic representation of nanoparticle‐mediated photothermal therapy (PTT) inducing anti‐tumor immune responses. Nanoparticles are administered to a tumor‐bearing mouse and accumulate at the tumor site. Upon laser irradiation, the nanoparticles generate reactive oxygen species (ROS) within cancer cells, leading to cellular apoptosis.
Alexander Chota +3 more
wiley +1 more source
Inter‐Nanoparticle FRET for Biosensing: Photophysics Versus Size
Förster resonance energy transfer (FRET) systems with luminescent nanoparticles (NPs) as donors and acceptors (inter‐NP FRET) combine unique photophysical properties with large sizes. This review discusses the influence of NP type, architecture, surface chemistry, and optical properties on FRET and the pros and cons of inter‐NP FRET for bioanalytical ...
Eduard Madirov +3 more
wiley +1 more source

